Page 1 of 1

2024-Revach et al-preprint

PostPosted: Thu Feb 15, 2024 5:30 pm
by mleipold
"Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy"
Or-Yam Revach, Angelina M Cicerchia, Ofir Shorer, Boryana Petrova, Seth Anderson, Josh Park, Lee Chen, Arnav Mehta, Samuel J Wright, Niamh McNamee, Aya Tal-Mason, Giulia Cattaneo, Payal Tiwari, Hongyan Xie, Johanna M Sweere, Li-Chun Cheng, Natalia Sigal, Elizabeth Enrico, Marisa Miljkovic, Shane A Evans, Ngan Nguyen, Mark E Whidden, Ramji Srinivasan, Matthew H Spitzer, Yi Sun, Tatyana Sharova, Aleigha Lawless, William A Michaud, Martin Q Rasmussen, Jacy Fang, Claire Palin, Feng Chen, Xinhui Wang, Cristina R Ferrone, Donald P Lawrence, Ryan J Sullivan, David Liu, Uma M Sachdeva, Debattama R Sen, Keith T Flaherty, Robert T Manguso, Lloyd Bod, Monolis Kellis, Genevieve M Boland, Keren Yizhak, Jiekun Yang, Naama Kanarek, Moshe Sade-Feldman, Nir Hacohen, Russell W Jenkins
bioRxiv, posted February 14, 2024
https://doi.org/10.1101/2024.02.12.579184

- will update when/if this is peer-reviewed and published

- no dataset accession given